Stock Events

Stock Events

Search...

Marker Therapeutics (MRKR) Q1 2026 Earnings

18MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.53

-0.39

-0.24

-0.1

Details

Expected EPS

-0.190767

Actual EPS

-0.1

Surprise EPS

0.09

Surprise Percent

+47.58%

Description

Marker Therapeutics (MRKR) has reported earnings of -0.1 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.